Jianjun Dong Selected Research

Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)

1/2018	Statins and Thyroid Carcinoma: a Meta-Analysis.
10/2016	Efficacy of statins in patients with diabetic nephropathy: a meta-analysis of randomized controlled trials.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jianjun Dong Research Topics

Disease

14	Neoplasms (Cancer) 02/2024 - 12/2016
11	Thyroid Neoplasms (Thyroid Cancer) 01/2023 - 01/2015
10	Type 2 Diabetes Mellitus (MODY) 06/2024 - 06/2016
4	Neoplasm Metastasis (Metastasis) 01/2022 - 12/2019
4	Insulin Resistance 01/2022 - 01/2019
4	Breast Neoplasms (Breast Cancer) 04/2021 - 12/2016
4	Diabetic Nephropathies (Diabetic Nephropathy) 02/2018 - 01/2014
3	Inflammation (Inflammations) 01/2024 - 01/2014
3	Fibrosis (Cirrhosis) 01/2024 - 01/2014
3	Carcinoma (Carcinomatosis) 12/2023 - 01/2020
3	Papillary Thyroid Cancer 01/2023 - 01/2014
2	Chronic Renal Insufficiency 06/2024 - 01/2024
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2024 - 01/2020
2	Proteinuria 01/2023 - 01/2014
2	Hypothyroidism 01/2023 - 12/2020
2	Lymphatic Metastasis 01/2023 - 01/2022
2	Obesity 10/2022 - 01/2021
2	Body Weight (Weight, Body) 10/2022 - 01/2019
2	Hyperlipidemias (Hyperlipidemia) 03/2020 - 01/2018
2	Albuminuria 01/2018 - 10/2016
2	Atherosclerosis 03/2015 - 01/2015
1	Hyperuricemia 03/2024
1	Carcinogenesis 02/2024
1	Nutrition Disorders (Nutritional Disorders) 02/2024
1	Weight Loss (Weight Reduction) 02/2024
1	Diabetes Mellitus 02/2024
1	Achondroplasia 01/2024
1	Acidosis 01/2023
1	Renal Tubular Acidosis (Distal Renal Tubular Acidosis) 01/2023
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023
1	Dyslipidemias (Dyslipidemia) 01/2023
1	Rare Diseases (Rare Disease) 01/2023
1	Hypokalemia 01/2023
1	Ischemia 01/2023
1	Nephrocalcinosis 01/2023
1	Wounds and Injuries (Trauma) 01/2023
1	Pituitary Neoplasms (Pituitary Adenoma) 01/2023
1	Infections 10/2022
1	Urinary Tract Infections (Urinary Tract Infection) 10/2022
1	Reproductive Tract Infections 10/2022
1	Respiratory Insufficiency (Respiratory Failure) 01/2022
1	Airway Obstruction (Choking) 01/2022
1	Mason-Type Diabetes 01/2022
1	Hyperinsulinism (Hyperinsulinemia) 01/2022
1	Tracheal Stenosis 01/2022
1	Overweight 01/2021

Drug/Important Bio-Agent (IBA)

6	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 01/2017
5	Hypoglycemic Agents (Hypoglycemics)IBA 02/2024 - 06/2014
5	Insulin (Novolin)FDA Link 01/2022 - 01/2017
3	Thyroid HormonesIBA 01/2023 - 01/2021
3	Triglycerides (Triacylglycerol)IBA 01/2023 - 01/2020
3	Metformin (Glucophage)FDA LinkGeneric 10/2022 - 02/2018
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2016
3	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 12/2020 - 05/2018
2	Mineralocorticoid Receptor AntagonistsIBA 06/2024 - 01/2024
2	Triiodothyronine (Liothyronine)FDA LinkGeneric 01/2023 - 05/2018
2	HDL CholesterolIBA 01/2023 - 10/2022
2	LipidsIBA 01/2023 - 03/2015
2	CholesterolIBA 01/2023 - 01/2020
2	Indicators and Reagents (Reagents)IBA 01/2022 - 01/2020
2	IodineIBA 01/2021 - 01/2014
2	Apolipoproteins E (ApoE)IBA 03/2020 - 03/2015
2	Chemokine ReceptorsIBA 01/2020 - 01/2015
2	Nevirapine (Viramune)FDA Link 01/2020 - 12/2019
2	sodium-iodide symporter (sodium iodide symporter)IBA 01/2020 - 01/2015
2	rhodiolosideIBA 01/2019 - 01/2018
2	Blood Glucose (Blood Sugar)IBA 01/2019 - 01/2017
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2018 - 10/2016
2	AlbuminsIBA 10/2016 - 01/2014
1	Uric Acid (Urate)IBA 03/2024
1	tirzepatideIBA 02/2024
1	Ubiquitin-Specific ProteasesIBA 02/2024
1	Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)IBA 01/2024
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2024
1	finerenoneIBA 01/2024
1	Claudin-2IBA 01/2024
1	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 01/2024
1	AgarIBA 11/2023
1	Thyroxine (Levothyroxine)FDA LinkGeneric 01/2023
1	ErbB Receptors (EGF Receptor)IBA 01/2023
1	Tyrosine Kinase InhibitorsIBA 01/2023
1	dirhodium tetraacetate (DRTA)IBA 01/2023
1	SeleniumIBA 01/2023
1	Carotenoids (Carotene)IBA 10/2022
1	fucoxanthinIBA 10/2022
1	C-PeptideIBA 01/2022
1	Hepatocyte Nuclear FactorsIBA 01/2022
1	Anesthetics (Anesthetic Agents)IBA 01/2022
1	Sodium-Glucose Transporter 2 InhibitorsIBA 11/2021
1	Streptozocin (Streptozotocin)FDA Link 09/2021
1	gliquidoneIBA 09/2021
1	Phenobarbital (Luminal)FDA Link 04/2021
1	Epidermal Growth Factor (EGF)IBA 04/2021

Therapy/Procedure

11	Therapeutics 02/2024 - 01/2014
3	Thyroidectomy 01/2023 - 01/2019
3	Neoadjuvant Therapy 01/2021 - 01/2019
2	Glycemic Control 02/2024 - 01/2017
1	Aftercare (After-Treatment) 12/2023
1	Extracorporeal Membrane Oxygenation 01/2022
1	Ovariectomy (Oophorectomy) 01/2021